NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.00M | 12.72M | 11.72M | 12.10M | 6.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.00M | 12.72M | 11.72M | 12.10M | 6.63M |
| Cost of Revenue | 9.83M | 9.58M | 9.13M | 8.94M | 7.85M |
| Gross Profit | 3.16M | 3.14M | 2.58M | 3.16M | -1.23M |
| SG&A Expenses | 7.77M | 7.21M | 7.23M | 7.38M | 7.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.00M | 3.00M | 3.00M | 0.00 | -3.00M |
| Total Operating Expenses | 20.60M | 19.79M | 19.36M | 16.32M | 12.30M |
| Operating Income | -7.60M | -7.07M | -7.65M | -4.23M | -5.67M |
| Income Before Tax | -7.15M | -6.64M | -6.83M | -3.61M | -5.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.15 | -6.64 | -6.83 | -3.61 | -5.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.15M | -6.64M | -6.83M | -3.61M | -5.34M |
| EBIT | -7.60M | -7.07M | -7.65M | -4.23M | -5.67M |
| EBITDA | -7.37M | -6.81M | -7.38M | -3.96M | -5.41M |
| EPS Basic | -0.84 | -0.80 | -0.99 | -0.47 | -0.95 |
| Normalized Basic EPS | -0.49 | -0.46 | -0.62 | -0.32 | -0.70 |
| EPS Diluted | -0.90 | -0.81 | -1.00 | -0.48 | -0.96 |
| Normalized Diluted EPS | -0.49 | -0.46 | -0.62 | -0.32 | -0.70 |
| Average Basic Shares Outstanding | 33.88M | 33.32M | 30.02M | 26.77M | 23.39M |
| Average Diluted Shares Outstanding | 33.96M | 33.32M | 30.02M | 26.78M | 23.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |